Detroit-based magnetic resonance imaging (MRI) technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations).

February 24, 2021 — Detroit-based magnetic resonance imaging (MRI) technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations). The acquisition brings an expert team of Ph.D. and master's-level engineers and physicists and also includes MR Innovations' 10 patents, over 300 published papers and a network of more than 50 global collaborators.

To honor the legacy of MR Innovations, the company, which currently does business under the name SpinTech Imaging, will rebrand to use the name SpinTech MRI.

"Our goal has always been to push the boundaries of what's possible with MRI while delivering practical solutions for the benefit of clinicians and patients along the way," said company CEO Ward Detwiler. "With the acquisition of MR Innovations, we're able to better pioneer the forefront of MRI technology while continually improving the present."

Joining SpinTech to provide fully-integrated research and development, MR Innovations also brings its expertise in protocol development for medical imaging scans, image processing services, clinical research organization consulting, and innovation in imaging hardware and software. "We are thrilled to provide end-to-end technology development for our MRI partners, radiologists, neurologists and researchers through this acquisition," said Detwiler.

In the past, MR Innovations and SpinTech have worked closely to create innovative technology for products such as STAGE, a standardized MRI software program allowing for improved efficiency and AI-assisted detection. STAGE technology allows for up to 40% faster MRI acquisition times for brain scans, improved visualization, and quantitative results with applications across conditions such as Parkinson's disease, dementia, traumatic brain injury, multiple sclerosis and stroke.

"With the expertise of our MR Innovations team members," said Founder and Chief Science Officer, E. Mark Haacke, Ph.D., "SpinTech MRI will now see medical imaging software production from base research to clinical deployment, continuing to lead MRI technology development with revolutionary ideas realized through fully supported software and products."

For more information: spintechimaging.com


Related Content

News | Cardiac Imaging

Aug. 20, 2026 – The novel, radiopaque, polymer-based embolic coil from Embolization, Inc. has now surpassed 125 implants ...

Time August 20, 2026
arrow
News | Computed Tomography (CT)

Aug. 13, 2026 — Aidoc has announced that the Centers for Medicare & Medicaid Services (CMS) has approved a New ...

Time August 18, 2026
arrow
Feature | Artificial Intelligence | Madhu Jahagirdar

Radiologists spend much of their day moving between different systems: One application to review images. Another to ...

Time August 17, 2026
arrow
News | X-Ray

Aug. 10, 2026 — Teledyne Technologies Inc. and Varex Imaging Corp. have jointly announced that they have entered into a ...

Time August 14, 2026
arrow
News | FDA

Aug. 1, 2026 — Candelis recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Time August 13, 2026
arrow
News | Artificial Intelligence

Aug. 10, 2026 — OSF HealthCare, a not-for-profit health system serving communities across Illinois and Michigan, and ...

Time August 12, 2026
arrow
News | Radiology Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Time August 10, 2026
arrow
News | Radiology Imaging

Aug. 4, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that the time between an imaging scan ...

Time August 06, 2026
arrow
News | Radiology Imaging

July 30, 2026 — João Seabra, head of Siemens Healthineers Enterprise Services, has been appointed president and Head of ...

Time August 06, 2026
arrow
News | Contrast Agents

Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...

Time August 05, 2026
arrow
Subscribe Now